Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emerging Vision is a prominent healthcare services company specializing in the optical retail sector. The company operates primarily as a franchisor, managing a network of eye care centers under well-recognized brands such as Sterling Optical and Site for Sore Eyes. These locations provide a range of services including comprehensive eye examinations, the sale of prescription eyewear, and contact lens fittings. Headquartered in Garden City, New York, Emerging Vision supports its franchisees with centralized purchasing, marketing, and operational expertise. In 2011, the company was acquired by the private equity firm Centre Lane Partners, transitioning from a publicly traded entity to a private portfolio company. It remains one of the largest franchisors of optical stores in the United States, focusing on high-quality patient care and retail excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emerging Vision.